David L. Keegan

1.4k total citations
36 papers, 1.1k citations indexed

About

David L. Keegan is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, David L. Keegan has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 7 papers in Clinical Psychology and 4 papers in Pharmacology. Recurrent topics in David L. Keegan's work include Schizophrenia research and treatment (6 papers), Treatment of Major Depression (3 papers) and Mental Health and Psychiatry (3 papers). David L. Keegan is often cited by papers focused on Schizophrenia research and treatment (6 papers), Treatment of Major Depression (3 papers) and Mental Health and Psychiatry (3 papers). David L. Keegan collaborates with scholars based in Canada, United States and Belgium. David L. Keegan's co-authors include Marcia M. Ward, Margaret A. Chesney, C. Barr Taylor, Ivan N. Mefford, Jack D. Barchas, John W. Hubbard, John Mikler, Ali H. Rajput, J. Scott Richardson and R. P. Liberman and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Schizophrenia Bulletin.

In The Last Decade

David L. Keegan

35 papers receiving 1.0k citations

Peers

Countries citing papers authored by David L. Keegan

Since Specialization

Citations

This map shows the geographic impact of David L. Keegan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Keegan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Keegan more than expected).

Fields of papers citing papers by David L. Keegan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Keegan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Keegan. The network helps show where David L. Keegan may publish in the future.

Co-authorship network of co-authors of David L. Keegan

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Keegan. A scholar is included among the top collaborators of David L. Keegan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Keegan. David L. Keegan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Taking the lead: Community pharmacists' perception of their role potential within the primary care team 2009 ·Research in Social and Administrative Pharmacy ·R. Dobson, Jeff Taylor, Carol J. Henry, Jean Lachaîne, Gordon A. Zello, David L. Keegan, Dorothy Forbes	35
2	Interprofessional health care teams: Attitudes and environmental factors associated with participation by community pharmacists 2006 ·Journal of Interprofessional Care ·R. Dobson, Carol J. Henry, Jeff Taylor, Gordon A. Zello, Jean Lachaîne, Dorothy Forbes, David L. Keegan	29
3	A qualitative analysis of the use of community treatment orders in Saskatchewan 2006 ·International Journal of Law and Psychiatry ·Richard L. O’Reilly, David L. Keegan, Deborah Corring, (unknown), (unknown)	49
4	Differential effects of olanzapine on the gene expression of superoxide dismutase and the low affinity nerve growth factor receptor 1999 ·Journal of Neuroscience Research ·Xinmin Li, Jennifer Chlan‐Fourney, Augusto V. Juorio, (unknown), (unknown), David L. Keegan, Qi Jin, Alan A. Boulton	52
5	Verbal learning by major depressive disorder patients during treatment with fluoxetine or amitriptyline 1994 ·International Clinical Psychopharmacology ·J. Scott Richardson, David L. Keegan, Rudy Bowen, (unknown), (unknown), Nilofer Dayal, Sohag Saleh, (unknown)	40
6	The noncompliance factor in the dexamethasone suppression test 1993 ·Biological Psychiatry ·Alfred J. Rémillard, Richard O’Reilly, Dennis K.J. Gorecki, (unknown), Declan Quinn, David L. Keegan	8
7	Longitudinal effect of amitriptyline and fluoxetine treatment on plasma phenylacetic acid concentrations in depression 1991 ·Biological Psychiatry ·Bruce A. Davis, Alan A. Boulton, (unknown), David A. Durden, David L. Keegan, Rudradeo C. Bowen, (unknown), (unknown), Alfred J. Rémillard, Nilofer Dayal, (unknown), (unknown), (unknown), I.A. Paterson	3
8	Deuterium-labelled p-tyramine challenge test and phenolsulfotransferase activity in depressed patients — failure to replicate decreased p-tyramine conjugation in depression 1991 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Bárbara Davis, A. A. Boulton, P. H. Yu, David A. Durden, Rudy Bowen, David L. Keegan, (unknown), (unknown), Alfred J. Rémillard, Nilofer Dayal, (unknown), (unknown)	5
9	At Issue: Defining Treatment Refractoriness in Schizophrenia 1990 ·Schizophrenia Bulletin ·H. D. Brenner, S. J. Dencker, Michael J. Goldstein, John W. Hubbard, David L. Keegan, Hendrik G. Kruger, (unknown), R. P. Liberman, Ulf Malm, K.K. Midha	190
10	Intersubject Variation in the Pharmacokinetics of Haloperidol and Reduced Haloperidol 1989 ·Journal of Clinical Psychopharmacology ·Kamal K. Midha, Bhaswat S. Chakraborty, Derek Ganes, (unknown), John W. Hubbard, David L. Keegan, E. D. Korchinski, Gordon McKay	46
11	Mental dysfunction and the blockade of muscarinic receptors in the brains of the normal elderly 1985 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·J. Steven Richardson, (unknown), (unknown), (unknown), (unknown), (unknown), David L. Keegan	20
12	Teaching Psychological Aspects of Medical Practice in Canadian Undergraduate Medical Curricula 1984 ·Academic Psychiatry ·David L. Keegan, (unknown)	1
13	Types of depression in alcoholic patients. 1984 ·PubMed ·Rudy Bowen, (unknown), Carl D’Arcy, David L. Keegan	16
14	Epinephrine and Norepinephrine Responses in Continuously Collected Human Plasma to a Series of Stressors 1983 ·Psychosomatic Medicine ·Marcia M. Ward, Ivan N. Mefford, (unknown), Margaret A. Chesney, C. Barr Taylor, David L. Keegan, Jack D. Barchas	143
15	Disorders of Sexual Desire and Other New Concepts and Techniques in Sex Therapy 1981 ·Psychosomatics ·David L. Keegan	4
16	Blindness: Some Psychological and Social Implications 1976 ·Canadian Psychiatric Association Journal ·David L. Keegan, (unknown), (unknown)	10
17	Adaptation to Visual Handicap: Short-Term Group Approach 1974 ·Psychosomatics ·David L. Keegan	8
18	Drug induced dystonia tarda: treatment with L-dopa. 1973 ·PubMed ·David L. Keegan, Ali H. Rajput	39
19	Psychosomatics: Toward An Understanding of Cardiovascular Disorders 1973 ·Psychosomatics ·David L. Keegan	4
20	The coronary patient: a psychosocial glimpse. 1973 ·PubMed ·David L. Keegan	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact